Latest news
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution - ca.finance.yahoo.comca.finance.yahoo.com · Mon, 10 Aug 2026 05:10:30 GMTOrganogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 08:12:57 GMTLayoff Tracker: Ensoma cuts jobs, narrows focus to lead asset - BioSpaceBioSpace · Fri, 07 Aug 2026 07:00:00 GMTOrganogenesis Launches New $75 Million At-The-Market Offering - TipRanksTipRanks · Thu, 06 Aug 2026 21:55:50 GMTOrganogenesis (Nasdaq: ORGO) sets up $75M at-the-market stock sale - Stock TitanStock Titan · Thu, 06 Aug 2026 20:46:10 GMTOrganogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMTOrganogenesis Announces Published RCT Results Showing Affinity Plus Standard of Care Improves Closure Rates in Complex Venous Leg Ulcers - Quiver QuantitativeQuiver Quantitative · Mon, 27 Jul 2026 20:13:00 GMT